Viroclinics-DDL COVID-19 Expertise Center

Accelerating COVID-19 research through state-of-the-art preclinical, clinical diagnostics

and global supply chain services

As SARS-CoV-2 continues to spread across the globe, we are committed to provide support for finding an effective immune and prophylactic strategy. We are currently working on many SARS-CoV-2 anti-viral and vaccine clinical trials. Viroclinics-DDL build further on an impressive track record of pandemic related viral targets, including SARS-CoV-1 (2002-2004) and S-OIV (2009) using validated molecular, cellular and preclinical analyses models. As a virology focused CRO we have extensive expertise with high-demand scenarios. To assist the pharmaceutical, biotech and academic communities with the development of anti-viral medication and vaccines against SARS-CoV-2, Viroclinics-DDL offers a full suite of preclinical, clinical diagnostic and global supply chain services.

COVID-19 Service Proposition

 Our service proposition includes:

Early stage and preclinical solutions

  • Validated animal models for SARS-CoV-2 challenge studies using wild type virus in our BSL3 facilities
  • Immunogenicity and efficacy testing

read more

Virological Assays

  • Viral culture/phenotyping
  • Plaque assays (High through plaque reduction assay available, 96-well format)

read more

Molecular Assays

  • Next Generation Sequencing, whole genome, targeted, including Bio-IT
  • Viral load qPCR

read more

Immunological Assays

  • Neutralizing antibodies
  • ELISA testing for antibodies

read more

Clinical Trial Operations Services

  • A global reach, through our network of 18 processing laboratories
  • Production and distribution of sample kits, including vials, labels, forms and coding
  • Global cold chain sample logistics.